Tandem Labs was built on partnerships with pharmaceutical companies providing creative methods development and validation of hundreds of proprietary compounds. We are currently building our suite of validated assays and welcome requests for assays that meet your specific needs.
Validated non-proprietary assays currently offered:
| List of Validated Assays | |||||
|---|---|---|---|---|---|
| ALL | A-F | G-L | M-R | S-Z | |
| COMPOUND | MATRIX | CALIBRATION RANGE | Anti-Coag | LTMS | TEMP |
|---|---|---|---|---|---|
| Acamprosate | Human Plasma | 0.500 to 200 ng/mL | - | ||
| AFMU | Human Urine | 100 - 20,000 ng/mL | None | 244 | -20 |
| Albuterol | Human Plasma | 1.00 - 1,000 pg/mL | |||
| Aliskiren | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 204 | -20 |
| Amlodipine | Human Plasma | 0.500 - 100 ng/mL | EDTA | 47 | -20 |
| Amprenavir | Human Plasma | 10.0 - 10,000 ng/mL | K3EDTA | 72 | -20 |
| Aprepitant | Human Plasma | 10.0 - 5,000 ng/mL | K3EDTA | 214 | -20 |
| Armodafinil | Human Plasma | 100 - 10,000 ng/mL | K3EDTA | 102 | -20 |
| Atazanavir | Human Plasma | 5.0 - 2,500 ng/mL | K2EDTA | 49 | -20,-70 |
| Atazanavir / Ritonavir | Human Plasma | 1.00 - 1,000 ng/mL | EDTA | -20 | |
| Atazanavir / Ritonavir | Human Plasma | 10.0 - 5,000 ng/mL | K3EDTA | 446 | -20 |
| Atorvastatin/ o-Hydroxy / p-Hydroxy | Human Plasma | 0.300 - 50.0 ng/mL | K2EDTA | 220 | -20 |
| Atorvastatin/ o-Hydroxy / p-Hydroxy | Human Plasma | 0.300 - 50.0 ng/mL | K2EDTA | 224 | -70 |
| Atorvastatin / Lactone / o-Hydroxy / p-Hydroxy | Human Plasma | 0.100 - 100 ng/mL | K2EDTA | 224 | -70 |
| Bortezomib | Human Plasma | 0.100 - 25.00 ng/mL | K2EDTA | 611 | -70 |
| Budesonide | Human Plasma | 10.0 to 5,000 pg/mL | K2EDTA | 123 | -20 |
| Buprenorphine/Norbuprenorphine | Human Plasma | 25.0 - 10,000 / 20 - 8,000 pg/mL | |||
| Buproprion/ Hydroxybuproprion/ Ethrohydroxybupropion / Threohydroxybuproprion |
Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA | 223 | -70 |
| Caffeine | Human Plasma | 10.0 - 10,000 ng/mL | K2EDTA | 223 | -20 |
| Capcitebine / 5'-Deoxy-5-fluorocytidine / 5'-Deoxy-5-fluorouidine | Human Plasma | 10.0 - 5,000 ng/mL | Na2 EDTA | 240 | -20 |
| Carboplatin | Human Plasma Ultrafiltrate |
50.0 - 40,000 ng/mL | K2EDTA | 262 | -70 |
| Carboplatin | Human Plasma | 100 - 50,000 ng/mL | |||
| Carvedilol | Human Plasma | 0.200 - 200 ng/mL | EDTA | 560 | -70 |
| Cinacalcet | Human Plasma | 0.100 - 50.00 ng/mL | K3EDTA | 252 | -20 |
| Ciprofloxacin / Levofloxacin / Moxifloxacin | Human Plasma | 10.0 - 1,000 ng/mL | |||
| Cyclobenzaprine | Human Plasma | 0.100 - 50.0 ng/mL | K2EDTA | 121 | -20 |
| Cytarabine/Ara-U | Human Plasma | 200 - 50,000 ng/mL | K2EDTA | 258 | -20 |
| Darifenacin | Human Plasma | 50.0 - 10,000 pg/mL | K2EDTA | 119 | -20 |
| Daunorubicin | Human Plasma | 0.100 - 10.0 ng/mL | EDTA | 200 | -70 |
| Daunorubicin/Daunorubicinol | Rat Plasma | 10.0 - 1,000 ng/mL | EDTA | 211 | -70 |
| Daunorubicin/Daunorubicinol | Dog Plasma | 10.0 - 1,000 ng/mL | EDTA | 211 | -70 |
| Dexlansoprazole | Human Plasma | 2.00 - 2,000 ng/mL | K2EDTA | 104 | -20 |
| Dexlansoprazole | Human Plasma | 2.00 - 2,000 ng/mL | K2EDTA | 84 | -70 |
| Dextromethorphan/Dextrorphan | Human Plasma | 0.500 - 250 ng/mL | K2EDTA | 273 | -20 |
| Dextromethorphan/Dextrorphan | Human Urine | 1.00 - 500 ng/mL | K2EDTA | 89 | -20 |
| Diclofenac | Human Plasma | 0.100 - 100 ng/mL | NaHep | 64 | -20 |
| Diclofenac | Human Plasma | 10.00 - 2,000 ng/mL | K2EDTA | 84 | -20 |
| Digoxin | Human Plasma | 0.100 to 50.0 ng/mL | K2EDTA | 177 | -20 |
| Docetaxel | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 80 | -20 |
| Donepezil | Human Plasma | 0.100 - 100 ng/mL | K3EDTA | 206 | -20 |
| Doxorubicin/Doxorubicinol | Human Plasma | 1.00 - 1,000 ng/mL | EDTA | 211 | -70 |
| Duloxetine | Human Plasma | 0.200 - 100 ng/mL | K3EDTA | 184 | -20 |
| Efavirenz | Human Plasma | 10.0 - 10,000 ng/mL | K2EDTA | 260 | -20 |
| Emtracitabine | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 330 | -20 |
| Entecavir | Human Plasma | 50.0 - 20,000 pg/mL | K2EDTA | 42,49 | -20,-70 |
| Erlotinib and Metabolite | Human Plasma | 10.0 - 4,000 ng/mL | K2EDTA | 315 | -70 |
| even | Human Plasma | 1.00 - 500 pg/mL | |||
| Estrone | Human Plasma | 5.00 - 2,500 pg/mL | |||
| Eszopiclone | Human Plasma | 1.00 - 100 ng/mL | K3EDTA | 235 | -20 |
| Ethinyl Estradiol | Human Plasma | 1.00 - 500 pg/mL | |||
| Famotidine | Human Plasma | 1.00 - 500 ng/mL | K3EDTA | 298 | -20 |
| Fentanyl | Human Plasma | 0.0500 - 50.0 ng/mL | K2EDTA | Pending | -20,-70 |
| Fluconazole | Human Plasma | 100 - 10,000 ng/mL | K3EDTA | 133 | -20 |
| 5-Fluorouracil | Human Plasma | 1.00 - 500 ng/mL | EDTA | 1095 | -20 |
| Fluticasone propionate / Salmeterol | Human Plasma | 1.00 - 200 pg/mL | K2EDTA/K3EDTA | 91 | -20 |
| Formoterol | Human Plasma | 10.0-10000 ng/mL | K2EDTA | ||
| Furosemide | Human Plasma | 10.0-10000 ng/mL | K2EDTA |